These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21896146)

  • 21. Short term effectiveness and hemodynamic actions of guanadrel, a new sympatholytic drug.
    Pascual AV; Julius S
    Curr Ther Res Clin Exp; 1972 Jul; 14(7):333-42. PubMed ID: 4625513
    [No Abstract]   [Full Text] [Related]  

  • 22. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [[Central agents in arterial hypertension: back to the future].
    Robles NR
    Nefrologia; 2000; 20(4):302-10. PubMed ID: 11039256
    [No Abstract]   [Full Text] [Related]  

  • 24. Side effects of sympatholytic antihypertensive drugs.
    Engelman K
    Hypertension; 1988 Mar; 11(3 Pt 2):II30-3. PubMed ID: 3280488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent.
    Prichard BN; Owens CW; Graham BR
    J Hum Hypertens; 1997 Aug; 11 Suppl 1():S29-45. PubMed ID: 9321737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sympathetic nervous system in salt-sensitive and obese hypertension: amelioration of multiple abnormalities by a central sympatholytic agent.
    Ernsberger P; Koletsky RJ; Collins LA; Bedol D
    Cardiovasc Drugs Ther; 1996 Jun; 10 Suppl 1():275-82. PubMed ID: 8827950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sympatholytic therapy in primary hypertension: a user friendly role for the future.
    DeQuattro V; Li D
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S118-23. PubMed ID: 11986908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Rilmenidine sympatholytic activity preserves mental and orthostatic sympathetic response and epinephrine secretion].
    Esler M; Lux A; Jennings G; Hastings J; Socratous F; Lambert G
    Arch Mal Coeur Vaiss; 2004; 97(7-8):786-92. PubMed ID: 15506067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New drugs for the treatment of hypertension.
    Mancia G; Stella ML; Grassi G
    Curr Opin Cardiol; 1999 Sep; 14(5):375-80. PubMed ID: 10500899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of centrally acting sympatholytic agents in the management of hypertension.
    Oster JR; Epstein M
    Arch Intern Med; 1991 Aug; 151(8):1638-44. PubMed ID: 1872668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Side effects of antihypertensive drugs.
    Chrysant SG; Frohlich ED
    Am Fam Physician; 1974 Jan; 9(1):94-101. PubMed ID: 4149117
    [No Abstract]   [Full Text] [Related]  

  • 32. I1-imidazoline-receptor agonists in the treatment of hypertension: an appraisal of clinical experience.
    Ollivier JP; Christen MO
    J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S39-48. PubMed ID: 7533226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of antihypertensive agents from various pharmacological groups on blood pressure reaction during stress-testing. Part I. Comparative characteristics of medications, exerting effect of sympathoadrenal block].
    Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA; Savel'eva SA
    Kardiologiia; 2008; 48(3):44-51. PubMed ID: 18429756
    [No Abstract]   [Full Text] [Related]  

  • 34. Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats.
    El-Mas MM; Omar AG; Helmy MM; Mohy El-Din MM
    Brain Res; 2009 Jan; 1248():96-106. PubMed ID: 19028461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The sympathetic nervous system as a target for the treatment of hypertension and cardiometabolic diseases.
    Sorota S
    J Cardiovasc Pharmacol; 2014 May; 63(5):466-76. PubMed ID: 24805148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic effects of moxonidine and other centrally acting antihypertensives.
    Schachter M
    Diabetes Obes Metab; 1999 Nov; 1(6):317-22. PubMed ID: 11225647
    [No Abstract]   [Full Text] [Related]  

  • 38. A critical role of sympathetic nerve regulation for the treatment of impaired daily rhythm in hypertensive Dahl rats.
    Suzuki J; Ogawa M; Tamura N; Maejima Y; Takayama K; Maemura K; Honda K; Hirata Y; Nagai R; Isobe M
    Hypertens Res; 2010 Oct; 33(10):1060-5. PubMed ID: 20668456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [How to treat effectively hypertensive patient with overactivity of sympathetic system?].
    Wańkowicz Z
    Pol Arch Med Wewn; 2002 Apr; 107(4):349-59. PubMed ID: 12189927
    [No Abstract]   [Full Text] [Related]  

  • 40. Practical clinical pharmacology of antihypertensive drugs.
    Gifford RW
    Cardiovasc Clin; 1975; 7(1):143-56. PubMed ID: 238740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.